| ■ 영문 제목 : Global Liposomal Products Market 2023-2027
|
 | ■ 상품코드 : IRTNTR71397-23
■ 조사/발행회사 : Technavio
■ 발행일 : 2023년 2월
■ 페이지수 : 약120
■ 작성언어 : 영문
■ 보고서 형태 : PDF
■ 납품 방식 : E메일 (24시간 이내)
■ 조사대상 지역 : 북미, 유럽, 아시아, 기타 지역
■ 산업 분야 : 의료
|
■ 판매가격 / 옵션
(부가세 10% 별도)
| Single User (1명 열람용) | USD2,500 ⇒환산￦3,375,000 | 견적의뢰/주문/질문 |
| Enterprise License (동일기업내 공유가능) | USD4,000 ⇒환산￦5,400,000 | 견적의뢰/주문/질문 |
※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.
|
Technavio사의 본 조사 보고서는 세계의 리포솜 제품 시장 규모가 2023년부터 2027년 사이에 3,183.63백만 달러에 이르며, 예측 기간 중 연평균 성장률은 9.65%가 될 것으로 전망하고 있습니다. 본 보고서는 세계의 리포솜 제품 시장에 대해 종합적인 조사를 실시하여, 개요, 시장 현황, 시장 규모 예측, 과거 시장 규모, Five Force 분석, 용도별 (암, 진균 감염증, 통증 관리, 바이러스 백신, 광선역학 요법) 분석, 종류별 (브랜드, 제네릭) 분석, 고객 현황, 지역별 (북미, 유럽, 아시아, 미국, 독일, 중국, 프랑스, 일본, 기타 지역) 분석, 기업 분석 등의 내용을 수록하고 있습니다. 또한 본 보고서는 Acthera Therapeutics AG, Bausch Health Companies Inc., Baxter International Inc., Galen Ltd., GENFIT SA, Gilead Sciences Inc., Innocan Pharma Corp. Ltd., Johnson and Johnson Services Inc., Leadiant Biosciences Inc., Lipella Pharmaceuticals Inc., Liposoma B.V. 와 같은 기업 정보를 포함하고 있습니다.
・개요
・시장 현황
・시장 규모 예측
・과거 시장 규모
・Five Force 분석
・세계의 리포솜 제품 시장 규모 : 용도별
- 암에 사용되는 리포솜 제품의 시장 규모
- 진균 감염증에 사용되는 리포솜 제품의 시장 규모
- 통증 관리에 사용되는 리포솜 제품의 시장 규모
- 바이러스 백신에 사용되는 리포솜 제품의 시장 규모
- 광역학적 요법에 사용되는 리포솜 제품의 시장 규모
・세계의 리포솜 제품 시장 규모 : 종류별
- 브랜드 리포솜 제품의 시장 규모
- 제네릭 리포솜 제품의 시장 규모
・고객 현황
・세계의 리포솜 제품 시장 규모 : 지역별
- 북미의 리포솜 제품 시장 규모
- 유럽의 리포솜 제품 시장 규모
- 아시아 리포솜 제품 시장 규모
- 미국의 리포솜 제품 시장 규모
- 독일의 리포솜 제품 시장 규모
- 중국의 리포솜 제품 시장 규모
- 프랑스의 리포솜 제품 시장 규모
- 일본의 리포솜 제품 시장 규모
- 기타 지역의 리포솜 제품 시장 규모
・성장 요인/과제/동향
・기업 현황
・기업 분석
Technavio 사는 이익, 가격, 경쟁, 프로모션과 같은 주요 매개 변수를 분석하여, 다수의 소스로부터 데이터를 조사, 통합 및 합산하여 리포솜 제품 시장에 대한 상세하고 종합적인 결과를 제공합니다. 또한, 주요 산업의 영향 요인을 분석하여 시장의 다양한 관점을 제시합니다. 제시된 데이터는 포괄적이고 신뢰할 수 있으며, 1차 및 2차에 걸친 광범위한 조사 결과입니다. 덧붙여 Technavio 사의 시장 조사 보고서는 정확한 리포솜 제품 시장 성장을 예측하기 위해, 정성적 및 정량적 조사를 사용하여, 명확한 경쟁 현황과 상세한 벤더 선택 방법 및 분석을 제공합니다. |
■ 보고서 개요Global Liposomal Products Market 2023-2027Technavio has been monitoring the liposomal products market and is forecast to grow by $3,183.63 mn during 2022-2027, accelerating at a CAGR of 9.65% during the forecast period. Our report on the liposomal products market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the rising incidence of fungal disorders, the growing prevalence of cancer cases, and side effects associated with cancer treatment.
Technavio’s liposomal products market is segmented as below:
By Application
• Cancer
• Fungal infections
• Pain management
• Viral vaccines
• Photodynamic therapy
By Type
• Branded
• Generic
By Geographical Landscape
• North America
• Europe
• Asia
• Rest of World (ROW)
This study identifies the rising adoption of quality by design (QBD) over traditional processes as one of the prime reasons driving the liposomal products market growth during the next few years. Also, increase in strategic collaboration and rising popularity of liposomal products with enhancing circulation time of hydrophobic substances will lead to sizable demand in the market.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the liposomal products market covers the following areas:
• Liposomal products market sizing
• Liposomal products market forecast
• Liposomal products market industry analysis
Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading liposomal products market vendors that include Acthera Therapeutics AG, Bausch Health Companies Inc., Baxter International Inc., Galen Ltd., GENFIT SA, Gilead Sciences Inc., Innocan Pharma Corp. Ltd., Johnson and Johnson Services Inc., Leadiant Biosciences Inc., Lipella Pharmaceuticals Inc., Liposoma B.V., Merrimack Pharmaceuticals Inc., Nanovex Biotechnologies SL, Pacira BioSciences Inc., Spectrum Pharmaceuticals Inc., Taiwan Liposome Co. Ltd., Takeda Pharmaceutical Co. Ltd., The Lubrizol Corp., Vascular Biosciences, and Viatris Inc. Also, the liposomal products market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
■ 보고서 목차• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Application
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Type
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global liposomal products market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on Global liposomal products market 2017 – 2021 ($ million)
o 4.2 Application Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – Application Segment 2017 – 2021 ($ million)
o 4.3 Type Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – Type Segment 2017 – 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
• 6 Market Segmentation by Application
o 6.1 Market segments
o Exhibit 30: Chart on Application – Market share 2022-2027 (%)
o Exhibit 31: Data Table on Application – Market share 2022-2027 (%)
o 6.2 Comparison by Application
o Exhibit 32: Chart on Comparison by Application
o Exhibit 33: Data Table on Comparison by Application
o 6.3 Cancer – Market size and forecast 2022-2027
o Exhibit 34: Chart on Cancer – Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Cancer – Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Cancer – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Cancer – Year-over-year growth 2022-2027 (%)
o 6.4 Fungal infections – Market size and forecast 2022-2027
o Exhibit 38: Chart on Fungal infections – Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Fungal infections – Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Fungal infections – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Fungal infections – Year-over-year growth 2022-2027 (%)
o 6.5 Pain management – Market size and forecast 2022-2027
o Exhibit 42: Chart on Pain management – Market size and forecast 2022-2027 ($ million)
o Exhibit 43: Data Table on Pain management – Market size and forecast 2022-2027 ($ million)
o Exhibit 44: Chart on Pain management – Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Pain management – Year-over-year growth 2022-2027 (%)
o 6.6 Viral vaccines – Market size and forecast 2022-2027
o Exhibit 46: Chart on Viral vaccines – Market size and forecast 2022-2027 ($ million)
o Exhibit 47: Data Table on Viral vaccines – Market size and forecast 2022-2027 ($ million)
o Exhibit 48: Chart on Viral vaccines – Year-over-year growth 2022-2027 (%)
o Exhibit 49: Data Table on Viral vaccines – Year-over-year growth 2022-2027 (%)
o 6.7 Photodynamic therapy – Market size and forecast 2022-2027
o Exhibit 50: Chart on Photodynamic therapy – Market size and forecast 2022-2027 ($ million)
o Exhibit 51: Data Table on Photodynamic therapy – Market size and forecast 2022-2027 ($ million)
o Exhibit 52: Chart on Photodynamic therapy – Year-over-year growth 2022-2027 (%)
o Exhibit 53: Data Table on Photodynamic therapy – Year-over-year growth 2022-2027 (%)
o 6.8 Market opportunity by Application
o Exhibit 54: Market opportunity by Application ($ million)
• 7 Market Segmentation by Type
o 7.1 Market segments
o Exhibit 55: Chart on Type – Market share 2022-2027 (%)
o Exhibit 56: Data Table on Type – Market share 2022-2027 (%)
o 7.2 Comparison by Type
o Exhibit 57: Chart on Comparison by Type
o Exhibit 58: Data Table on Comparison by Type
o 7.3 Branded – Market size and forecast 2022-2027
o Exhibit 59: Chart on Branded – Market size and forecast 2022-2027 ($ million)
o Exhibit 60: Data Table on Branded – Market size and forecast 2022-2027 ($ million)
o Exhibit 61: Chart on Branded – Year-over-year growth 2022-2027 (%)
o Exhibit 62: Data Table on Branded – Year-over-year growth 2022-2027 (%)
o 7.4 Generic – Market size and forecast 2022-2027
o Exhibit 63: Chart on Generic – Market size and forecast 2022-2027 ($ million)
o Exhibit 64: Data Table on Generic – Market size and forecast 2022-2027 ($ million)
o Exhibit 65: Chart on Generic – Year-over-year growth 2022-2027 (%)
o Exhibit 66: Data Table on Generic – Year-over-year growth 2022-2027 (%)
o 7.5 Market opportunity by Type
o Exhibit 67: Market opportunity by Type ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 69: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 70: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 71: Chart on Geographic comparison
o Exhibit 72: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2022-2027
o Exhibit 73: Chart on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 74: Data Table on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 75: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 76: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.4 Europe – Market size and forecast 2022-2027
o Exhibit 77: Chart on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 78: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 79: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 80: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.5 Asia – Market size and forecast 2022-2027
o Exhibit 81: Chart on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 82: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 83: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 84: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 85: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 86: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 87: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 88: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 89: Chart on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 90: Data Table on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 91: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 92: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 Germany – Market size and forecast 2022-2027
o Exhibit 93: Chart on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 94: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 95: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 96: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 9.9 China – Market size and forecast 2022-2027
o Exhibit 97: Chart on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 98: Data Table on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 99: Chart on China – Year-over-year growth 2022-2027 (%)
o Exhibit 100: Data Table on China – Year-over-year growth 2022-2027 (%)
o 9.10 France – Market size and forecast 2022-2027
o Exhibit 101: Chart on France – Market size and forecast 2022-2027 ($ million)
o Exhibit 102: Data Table on France – Market size and forecast 2022-2027 ($ million)
o Exhibit 103: Chart on France – Year-over-year growth 2022-2027 (%)
o Exhibit 104: Data Table on France – Year-over-year growth 2022-2027 (%)
o 9.11 Japan – Market size and forecast 2022-2027
o Exhibit 105: Chart on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 106: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 107: Chart on Japan – Year-over-year growth 2022-2027 (%)
o Exhibit 108: Data Table on Japan – Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 109: Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 110: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 111: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 112: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 113: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 114: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 115: Matrix on vendor position and classification
o 12.3 Acthera Therapeutics AG
o Exhibit 116: Acthera Therapeutics AG – Overview
o Exhibit 117: Acthera Therapeutics AG – Product / Service
o Exhibit 118: Acthera Therapeutics AG – Key offerings
o 12.4 Bausch Health Companies Inc.
o Exhibit 119: Bausch Health Companies Inc. – Overview
o Exhibit 120: Bausch Health Companies Inc. – Business segments
o Exhibit 121: Bausch Health Companies Inc. – Key news
o Exhibit 122: Bausch Health Companies Inc. – Key offerings
o Exhibit 123: Bausch Health Companies Inc. – Segment focus
o 12.5 Baxter International Inc.
o Exhibit 124: Baxter International Inc. – Overview
o Exhibit 125: Baxter International Inc. – Business segments
o Exhibit 126: Baxter International Inc. – Key news
o Exhibit 127: Baxter International Inc. – Key offerings
o Exhibit 128: Baxter International Inc. – Segment focus
o 12.6 Galen Ltd.
o Exhibit 129: Galen Ltd. – Overview
o Exhibit 130: Galen Ltd. – Product / Service
o Exhibit 131: Galen Ltd. – Key offerings
o 12.7 Gilead Sciences Inc.
o Exhibit 132: Gilead Sciences Inc. – Overview
o Exhibit 133: Gilead Sciences Inc. – Product / Service
o Exhibit 134: Gilead Sciences Inc. – Key news
o Exhibit 135: Gilead Sciences Inc. – Key offerings
o 12.8 Innocan Pharma Corp. Ltd.
o Exhibit 136: Innocan Pharma Corp. Ltd. – Overview
o Exhibit 137: Innocan Pharma Corp. Ltd. – Product / Service
o Exhibit 138: Innocan Pharma Corp. Ltd. – Key offerings
o 12.9 Johnson and Johnson Services Inc.
o Exhibit 139: Johnson and Johnson Services Inc. – Overview
o Exhibit 140: Johnson and Johnson Services Inc. – Business segments
o Exhibit 141: Johnson and Johnson Services Inc. – Key news
o Exhibit 142: Johnson and Johnson Services Inc. – Key offerings
o Exhibit 143: Johnson and Johnson Services Inc. – Segment focus
o 12.10 Leadiant Biosciences Inc.
o Exhibit 144: Leadiant Biosciences Inc. – Overview
o Exhibit 145: Leadiant Biosciences Inc. – Product / Service
o Exhibit 146: Leadiant Biosciences Inc. – Key offerings
o 12.11 Liposoma B.V.
o Exhibit 147: Liposoma B.V. – Overview
o Exhibit 148: Liposoma B.V. – Product / Service
o Exhibit 149: Liposoma B.V. – Key offerings
o 12.12 Merrimack Pharmaceuticals Inc.
o Exhibit 150: Merrimack Pharmaceuticals Inc. – Overview
o Exhibit 151: Merrimack Pharmaceuticals Inc. – Product / Service
o Exhibit 152: Merrimack Pharmaceuticals Inc. – Key offerings
o 12.13 Pacira BioSciences Inc.
o Exhibit 153: Pacira BioSciences Inc. – Overview
o Exhibit 154: Pacira BioSciences Inc. – Business segments
o Exhibit 155: Pacira BioSciences Inc. – Key offerings
o Exhibit 156: Pacira BioSciences Inc. – Segment focus
o 12.14 Spectrum Pharmaceuticals Inc.
o Exhibit 157: Spectrum Pharmaceuticals Inc. – Overview
o Exhibit 158: Spectrum Pharmaceuticals Inc. – Product / Service
o Exhibit 159: Spectrum Pharmaceuticals Inc. – Key offerings
o 12.15 Takeda Pharmaceutical Co. Ltd.
o Exhibit 160: Takeda Pharmaceutical Co. Ltd. – Overview
o Exhibit 161: Takeda Pharmaceutical Co. Ltd. – Product / Service
o Exhibit 162: Takeda Pharmaceutical Co. Ltd. – Key news
o Exhibit 163: Takeda Pharmaceutical Co. Ltd. – Key offerings
o 12.16 The Lubrizol Corp.
o Exhibit 164: The Lubrizol Corp. – Overview
o Exhibit 165: The Lubrizol Corp. – Product / Service
o Exhibit 166: The Lubrizol Corp. – Key offerings
o 12.17 Viatris Inc.
o Exhibit 167: Viatris Inc. – Overview
o Exhibit 168: Viatris Inc. – Business segments
o Exhibit 169: Viatris Inc. – Key offerings
o Exhibit 170: Viatris Inc. – Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 171: Inclusions checklist
o Exhibit 172: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 173: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 174: Research methodology
o Exhibit 175: Validation techniques employed for market sizing
o Exhibit 176: Information sources
o 13.5 List of abbreviations
o Exhibit 177: List of abbreviations
Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Application
Exhibits6: Executive Summary – Chart on Market Segmentation by Type
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on Global liposomal products market 2017 – 2021 ($ million)
Exhibits19: Historic Market Size – Application Segment 2017 – 2021 ($ million)
Exhibits20: Historic Market Size – Type Segment 2017 – 2021 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on Application – Market share 2022-2027 (%)
Exhibits31: Data Table on Application – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Application
Exhibits33: Data Table on Comparison by Application
Exhibits34: Chart on Cancer – Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Cancer – Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Cancer – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Cancer – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Fungal infections – Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Fungal infections – Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Fungal infections – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Fungal infections – Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Pain management – Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Pain management – Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Pain management – Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Pain management – Year-over-year growth 2022-2027 (%)
Exhibits46: Chart on Viral vaccines – Market size and forecast 2022-2027 ($ million)
Exhibits47: Data Table on Viral vaccines – Market size and forecast 2022-2027 ($ million)
Exhibits48: Chart on Viral vaccines – Year-over-year growth 2022-2027 (%)
Exhibits49: Data Table on Viral vaccines – Year-over-year growth 2022-2027 (%)
Exhibits50: Chart on Photodynamic therapy – Market size and forecast 2022-2027 ($ million)
Exhibits51: Data Table on Photodynamic therapy – Market size and forecast 2022-2027 ($ million)
Exhibits52: Chart on Photodynamic therapy – Year-over-year growth 2022-2027 (%)
Exhibits53: Data Table on Photodynamic therapy – Year-over-year growth 2022-2027 (%)
Exhibits54: Market opportunity by Application ($ million)
Exhibits55: Chart on Type – Market share 2022-2027 (%)
Exhibits56: Data Table on Type – Market share 2022-2027 (%)
Exhibits57: Chart on Comparison by Type
Exhibits58: Data Table on Comparison by Type
Exhibits59: Chart on Branded – Market size and forecast 2022-2027 ($ million)
Exhibits60: Data Table on Branded – Market size and forecast 2022-2027 ($ million)
Exhibits61: Chart on Branded – Year-over-year growth 2022-2027 (%)
Exhibits62: Data Table on Branded – Year-over-year growth 2022-2027 (%)
Exhibits63: Chart on Generic – Market size and forecast 2022-2027 ($ million)
Exhibits64: Data Table on Generic – Market size and forecast 2022-2027 ($ million)
Exhibits65: Chart on Generic – Year-over-year growth 2022-2027 (%)
Exhibits66: Data Table on Generic – Year-over-year growth 2022-2027 (%)
Exhibits67: Market opportunity by Type ($ million)
Exhibits68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits69: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits70: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits71: Chart on Geographic comparison
Exhibits72: Data Table on Geographic comparison
Exhibits73: Chart on North America – Market size and forecast 2022-2027 ($ million)
Exhibits74: Data Table on North America – Market size and forecast 2022-2027 ($ million)
Exhibits75: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits76: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits77: Chart on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits78: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits79: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits80: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits81: Chart on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits82: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits83: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits86: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits87: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on US – Market size and forecast 2022-2027 ($ million)
Exhibits90: Data Table on US – Market size and forecast 2022-2027 ($ million)
Exhibits91: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits94: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits95: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits97: Chart on China – Market size and forecast 2022-2027 ($ million)
Exhibits98: Data Table on China – Market size and forecast 2022-2027 ($ million)
Exhibits99: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibits100: Data Table on China – Year-over-year growth 2022-2027 (%)
Exhibits101: Chart on France – Market size and forecast 2022-2027 ($ million)
Exhibits102: Data Table on France – Market size and forecast 2022-2027 ($ million)
Exhibits103: Chart on France – Year-over-year growth 2022-2027 (%)
Exhibits104: Data Table on France – Year-over-year growth 2022-2027 (%)
Exhibits105: Chart on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits106: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits107: Chart on Japan – Year-over-year growth 2022-2027 (%)
Exhibits108: Data Table on Japan – Year-over-year growth 2022-2027 (%)
Exhibits109: Market opportunity By Geographical Landscape ($ million)
Exhibits110: Impact of drivers and challenges in 2022 and 2027
Exhibits111: Overview on Criticality of inputs and Factors of differentiation
Exhibits112: Overview on factors of disruption
Exhibits113: Impact of key risks on business
Exhibits114: Vendors covered
Exhibits115: Matrix on vendor position and classification
Exhibits116: Acthera Therapeutics AG – Overview
Exhibits117: Acthera Therapeutics AG – Product / Service
Exhibits118: Acthera Therapeutics AG – Key offerings
Exhibits119: Bausch Health Companies Inc. – Overview
Exhibits120: Bausch Health Companies Inc. – Business segments
Exhibits121: Bausch Health Companies Inc. – Key news
Exhibits122: Bausch Health Companies Inc. – Key offerings
Exhibits123: Bausch Health Companies Inc. – Segment focus
Exhibits124: Baxter International Inc. – Overview
Exhibits125: Baxter International Inc. – Business segments
Exhibits126: Baxter International Inc. – Key news
Exhibits127: Baxter International Inc. – Key offerings
Exhibits128: Baxter International Inc. – Segment focus
Exhibits129: Galen Ltd. – Overview
Exhibits130: Galen Ltd. – Product / Service
Exhibits131: Galen Ltd. – Key offerings
Exhibits132: Gilead Sciences Inc. – Overview
Exhibits133: Gilead Sciences Inc. – Product / Service
Exhibits134: Gilead Sciences Inc. – Key news
Exhibits135: Gilead Sciences Inc. – Key offerings
Exhibits136: Innocan Pharma Corp. Ltd. – Overview
Exhibits137: Innocan Pharma Corp. Ltd. – Product / Service
Exhibits138: Innocan Pharma Corp. Ltd. – Key offerings
Exhibits139: Johnson and Johnson Services Inc. – Overview
Exhibits140: Johnson and Johnson Services Inc. – Business segments
Exhibits141: Johnson and Johnson Services Inc. – Key news
Exhibits142: Johnson and Johnson Services Inc. – Key offerings
Exhibits143: Johnson and Johnson Services Inc. – Segment focus
Exhibits144: Leadiant Biosciences Inc. – Overview
Exhibits145: Leadiant Biosciences Inc. – Product / Service
Exhibits146: Leadiant Biosciences Inc. – Key offerings
Exhibits147: Liposoma B.V. – Overview
Exhibits148: Liposoma B.V. – Product / Service
Exhibits149: Liposoma B.V. – Key offerings
Exhibits150: Merrimack Pharmaceuticals Inc. – Overview
Exhibits151: Merrimack Pharmaceuticals Inc. – Product / Service
Exhibits152: Merrimack Pharmaceuticals Inc. – Key offerings
Exhibits153: Pacira BioSciences Inc. – Overview
Exhibits154: Pacira BioSciences Inc. – Business segments
Exhibits155: Pacira BioSciences Inc. – Key offerings
Exhibits156: Pacira BioSciences Inc. – Segment focus
Exhibits157: Spectrum Pharmaceuticals Inc. – Overview
Exhibits158: Spectrum Pharmaceuticals Inc. – Product / Service
Exhibits159: Spectrum Pharmaceuticals Inc. – Key offerings
Exhibits160: Takeda Pharmaceutical Co. Ltd. – Overview
Exhibits161: Takeda Pharmaceutical Co. Ltd. – Product / Service
Exhibits162: Takeda Pharmaceutical Co. Ltd. – Key news
Exhibits163: Takeda Pharmaceutical Co. Ltd. – Key offerings
Exhibits164: The Lubrizol Corp. – Overview
Exhibits165: The Lubrizol Corp. – Product / Service
Exhibits166: The Lubrizol Corp. – Key offerings
Exhibits167: Viatris Inc. – Overview
Exhibits168: Viatris Inc. – Business segments
Exhibits169: Viatris Inc. – Key offerings
Exhibits170: Viatris Inc. – Segment focus
Exhibits171: Inclusions checklist
Exhibits172: Exclusions checklist
Exhibits173: Currency conversion rates for US$
Exhibits174: Research methodology
Exhibits175: Validation techniques employed for market sizing
Exhibits176: Information sources
Exhibits177: List of abbreviations
|
| ※본 조사보고서 [세계의 리포솜 제품 시장 (2023년~2027년)] (코드 : IRTNTR71397-23) 판매에 관한 면책사항을 반드시 확인하세요. |
| ※본 조사보고서 [세계의 리포솜 제품 시장 (2023년~2027년)] 에 대해서 E메일 문의는 여기를 클릭하세요. |
※당 사이트에 없는 보고서도 취급 가능한 경우가 많으니 문의 주세요!
